Research Paper Volume 12, Issue 11 pp 10844—10862
Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer
Figure 1. Patient selection process and classification. Overall patient selection process and their classification based on types of diseases.